OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to create unique multi-marker assays for use in the discrimination of patient response to drug therapies and apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level. This is of particular benefit to the pharmaceutical and health authority sectors.
|Size (employees)||17 (est)|
Oncomark total Funding
Oncomark latest funding size
Time since last funding
|2 years ago|
|Horizon 2020, Enterprise Ireland, Irrus Investments, Kernel Capital, Bank of Ireland|
Oncomark has 301 Twitter Followers. The number of followers has increased 1.4% month over month and increased 5.2% quarter over quarter
When was Oncomark founded?
Oncomark was founded in 2007.
Who are Oncomark key executives?
Oncomark's key executives are Desmond OLeary, Stephen Penney and William Gallagher.
How many employees does Oncomark have?
Oncomark has 17 employees.
Who are Oncomark competitors?
Competitors of Oncomark include Kiniksa Pharmaceuticals, Sartorius Stedim BioOutsource and Neurosearch.
Where is Oncomark headquarters?
Oncomark headquarters is located at University College Dublin Stillorgan Rd, Belfield.
Where are Oncomark offices?
Oncomark has an office in Belfield.
How many offices does Oncomark have?
Oncomark has 1 office.